A bid to boost coordination on medicine patents; European researchers seek a greater stake in drug development

Taking stock of the drug industry, from the lab to the medicine chest ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by        STAT+: Senate lawmakers introduce a bill to help the FDA and the U.S. Patent Office coordinate By Ed Silverman Adobe The new bill would require the FDA and the Patent & Trademark Office to create a task force that boosts coordination between the two. Read More STAT+: European researchers seek greater stake in drug development in bid to improve access By Jessica Davis Plüss Pierre Crom/Getty Images The effort has had some success with medicines destined for low-income countries, but has faced hurdles in Europe itself. Read More STAT+: Supreme Court rules in favor of insurance plan that pushed kidney failure patient to Medicare By Bob Herman Rich Pedroncelli/AP The Supreme Court on Tuesday ruled in favor of an insurance plan that pushed a kidney failure patient to Medicare. Read More Sponsor content by InCrowd How pharmaceutical market researchers can get the most from benchmarks When applied correctly, benchmarks can improve performance and set the standard for success. But when are benchmarks most effective? Building Better Benchmarks, a free webinar, will explore how to leverage benchmarks to enhance analysis framing, demonstrate social proof, and minimize costs. Join InCrowd industry experts on Tuesday, June 28th at 1:00 pm ET for best practices in benchmarking with real-world examples. Register today. STAT+: PTC's Duchenne muscular dystrophy drug achieves study goal, potentially confirming European approval By Adam Feuerstein Kristoffer Tripplaar/Alamy A separate analysis of the same study data that might allow PTC to seek approval in the U.S. failed to reach statistical significance. Read More Opinion: The U.S. needs to revitalize research on the health effects of low-dose radiation By Joe Gray and Lindsay Morton and Gayle Woloschak Adobe Research on the health effects of low-dose radiation has been de-prioritized in recent years. The U.S. needs to revitalize it. Read More Tuesday, June 21, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser